Search results :

Guanfacine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C02AC02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4
Dry mouth postmarketing, 2% - 60% 0% - 6.85% x x x x
Somnolence postmarketing, 18% - 38% 1.37% - 12% x x x x
Drowsiness 6% - 33% x x x
Dizziness postmarketing, 1% - 15% 2.74% - 8% x x x x
Fatigue postmarketing, 2% - 14% 2% - 4.11% x x x x
Decreased appetite 5% - 7% 3% - 4% x
Irritability 6% 4% x
Lethargy 6% 3% x
Constipation postmarketing, 2% - 14% 0% - 1% x x x x
Headache postmarketing, 0.2% - 24% 4.11% - 19% x x x x
Hypotension 3% - 7% 0% - 3% x
Insomnia postmarketing, 0% - 12% 6% x x x x
Affect lability 2% 1% x
Asthenia postmarketing, 1% - 5% 0% x x x x
Abdominal pain postmarketing, 10% - 11% 3% - 9% x x x x
Alopecia postmarketing x x x x
Anxiety postmarketing x x x x
Arthralgia postmarketing x x x x
Chest pain postmarketing x x x x
Confusional state postmarketing x x x x
Dermatitis postmarketing x x x x
Dermatitis exfoliative postmarketing x x x x
Diarrhoea postmarketing, 4% 1% x x x x
Dysgeusia postmarketing x x x x
Dyspepsia postmarketing x x x x
Dyspnoea postmarketing x x x x
Oedema postmarketing x x x x
Rash postmarketing x x x x
Eye disorder postmarketing x x x x
Hallucination postmarketing x
Block heart postmarketing x x x
Cardiac failure congestive postmarketing x x x
Renal failure acute postmarketing x x x
Cramps of lower extremities postmarketing x x x x
Leg pain postmarketing x x x x
Myocardial infarction postmarketing x x x
Nausea postmarketing, 5% - 6% 2% - 3% x x x x
Nervousness postmarketing x x x
Nocturia postmarketing x x x
Palpitations postmarketing x x x x
Paraesthesia postmarketing x x x x
Pruritus postmarketing x x x x
Cerebrovascular accident postmarketing x x x
Syncope postmarketing x x x x
Tachycardia postmarketing x x x x
Tremor postmarketing x x x x
Pollakiuria postmarketing x x x x
Vertigo postmarketing x x x x
Agitation postmarketing x x x x
Liver function test abnormal postmarketing x x x
Malaise postmarketing x x x x
Myalgia postmarketing x x x x
Cardiac fibrillation postmarketing x x x
Erectile dysfunction postmarketing 0% - 1.37% x x x x
Vision blurred postmarketing x x x x
Bradycardia postmarketing, 2% 0% x x x x
Amnesia x x x
Sinus arrhythmia x
Asthma x
Atrioventricular block x
Conjunctivitis x x x
Dysphagia x x x
Enuresis x
Hypersensitivity x
Orthostatic hypotension x x x x
Immune system disorder x
Iritis x x x
Nightmare x x x x
Pallor x
Paresis x x x
Purpura x x x
Rhinitis x x x
Convulsion x
Sweating x x x
Testicular disorder x x x
Tinnitus x x x
Urinary incontinence x x x
Vomiting x
Weight increased x
Hypokinesia x x x
Retrosternal pain x x x
Alanine aminotransferase increased x
Abdominal pain upper x
Abdominal pain lower x
Upset stomach x
Skin exfoliation x x x
Initial insomnia x
Middle insomnia x
Hypertensive x x x
Hypersomnia x
Loss of libido x x x
Visual impairment x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

GUANFACINE

Side effects:65
Source:FDA Structured Product Label

Guanfacine

Side effects:69
Source:FDA Structured Product Label

Guanfacine

Side effects:69
Source:FDA Structured Product Label

GUANFACINE

Side effects:69
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label